creation date: 2026-06-19 17:20
tags: Pathologies
Serotonin Syndrome
Background
Definitions
Serotonin syndrome, or serotonin toxicity, is a potentially life-threatening condition.
Etiology & Risk Factors
Serotonin syndrome may occur due to:
- Therapeutic medication use
- Inadvertent interactions between drugs
- Intentional self-poisoning
The most common cause is the use of SSRIs, however, more severe serotonin syndrome is associated with medications that inhibit monoamine oxidase. In generally, risk increases as SSRI > SNRI > MAOI.
Risk is classically associated with simultaneous use of two serotonergic agents (or in the case of long-half life options, on swap) but can occur with a dose increase or at initiation of a single agent.
It should be noted that serotonergic agonist activity (eg. fentanyl, buspirone, LSD, triptans) are less likely to cause classic serotonin syndrome.
Pathogenesis
Serotonin syndrome occurs as a result of excess serotonergic neurotransmission. This commonly due to medications which increase serotonin activity. No single receptor has been implicated as solely responsible but postsynaptic 5-HT1A and 5-HT2A receptors have been suggested.
In the CNS, serotonin modulates attention, behaviour, and thermoregulation. In the PNS, serotonin, which is produced by intestinal cells, are involved in gastrointestinal motility, vasoconstriction, uterine contraction, and bronchoconstriction. Serotonin also promotes platelet aggregation.
Clinical Presentation
Signs & Symptoms
Findings typically present within 24 hours (most within 6 hours) of a change in dose or initiation of a drug.
Mental status changes
- Anxiety
- Restlessness
- Disorientation
- Delirium
- Agitation
Autonomic manifestations
- Diaphoresis
- Tachycardia
- Hyperthermia
- Hypertension
- Vomiting/diarrhea
Neuromuscular hyperactivity
- Tremor
- Myoclonus
- Hyperreflexia
- Bilateral Babinski sign
- Seizure (often fatal, preterminal event)
History & Physical Exam
History includes:
- Complete medication history including prescription, OTC, illicit, and dietary supplements
- Any changes in dosing and schedule
- Symptoms onset and rate of change
- Intent vs. accidental ingestion
- Comorbid conditions
Physical exam should include full vitals and a neurological exam, including:
- Ocular findings
- Tremors
- Hyperreflexia and other upper neuron signs
- Fluid status
Diagnosis
Criteria
Diagnosis is made clinically. Serum serotonin levels do not correlate with clinical findings. One of the following present in setting of serotonergic agent meets diagnostic criteria:
- Spontaneous clonus
- Inducible clonus PLUS agitation or diaphoresis
- Ocular clonus PLUS agitation or diaphoresis
- Tremor PLUS hyperreflexia
- Hypertonia PLUS temperature above 38C PLUS ocular clonus or inducible clonus
Note that in most cases, diagnosis does not require exclusion of other diagnoses, overdose with one or drug-drug interaction of two direct serotonin receptor agonist requires exclusion due to the lower chance of causing serotonin syndrome.
Work-up
In cases of severe disease or consideration of differential diagnoses, the following studies may be necessary:
- CBC
- Electrolytes
- BUN and creatinine
- Creatine phosphokinase
- Liver chemistries
- Coagulation studies
- Blood culture
- Urinalysis
- Plain chest radiograph
- CSF analysis and culture
- Head CT
In cases of intentional overdose:
- Acetaminophen levels
- Salicylate levels
- ECG
Differential
Differential diagnosis includes:
- Neuroleptic malignant syndrome - longer onset (days to weeks vs. 24 hours), sluggish response (vs. hyperreactivity)
- Anticholinergic toxicity
- Acute extrapyramidal syndromes (from antipsychotics)
- Malignant hyperthermia
- Other toxidromes
- Thyroid storm
Somewhat similarly, carcinoid syndrome may have peripheral findings of serotonin excess.
Red Flags / Complications
Severe disease may result in severe complications:
- Disseminated intravascular coagulation
- Rhabdomyolysis
- Metabolic Acidosis
- Kidney failure
- Myoglobinuria
- Acute respiratory distress syndrome
Management
Care depends on severity:
- For mild cases, discontinuation, supportive care, and sedation is often sufficient
- In moderate cases, further use of serotonin antagonist in a more intensive setting (eg. with vital monitoring) may be needed
- Severe cases often require neuromuscular paralysis, intubation, and ICU care
General Measures
Discontinuation of serotonergic agents
For all cases, inciting medications should be discontinued. Generally, resolution occurs within 24 hours but medications with longer half lives (especially irreversible MAOIs)
can persist for longer.
Consider consultation with toxicology or poison centre.
Supportive care
Supportive care consist of:
- Supplemental oxygen
- IV fluids
- Correction of vital signs (especially hyperthermia)
Sedation
For patients with agitation, benzodiazepines are used for control and for correcting mild changes in blood pressure and heart rate. Repeated q8-10 mins based on response:
- Lorazepam 2-4 mg IV
- Diazepam 5-10 mg IV
Note, physical restraints are not recommend as isometric muscle contracts can lead to lactic acidosis and worsening hyperthermia.
Treatment of Specific Manifestations
Treatment of autonomic instability
Management of vitals may be difficult as severe cases often have large and rapid changes in blood pressure and heart rate. As such, short-acting medications are preferred.
For severe hypertension and tachycardia, one of the following can be titrated to maintain autonomic stability:
- Esmolol
- Nicardipine
- Nitroprusside
For severe hypotension with MAOIs, direct-acting sympathomimetics (eg. phenylephrine, epinephrine, norepinephrine) should be used as indirect agents (eg. dopamine) are metabolized to epinephrine and norepinephrine which are uncontrolled without MAO.
Treatment of severe hyperthermia
For patients with hyperthermia requires cooling and elimination of excessive muscle activity. In severe cases (temperature >41ºC), patients require:
- Tracheal intubation via RSI procedures
- Neuromuscular paralysis (eg. with vecuronium)
- Sedation (eg. benzodiazepine, propofal, or dexmedetomidine)
Note that antipyretic agents are ineffective as the elevated body temperature is due to muscle activity and not due to an altered hypothalamic temperature set point.
Treatment of Persistent Symptoms
Serotonin antagonists
If the above management fails to improve agitation and correct vital signs, antidotal therapy with cyproheptadine can be considered. This medication has:
- H1 antihistamine antagonism
- Nonspecific 5-HT1A and 5-HT2A serotonin receptor antagonism
- Weak anticholinergic activity
Other options with 5-HT2A antagonism activity such as antipsychotics have no evidence for their use and thus not recommended.
Disposition
Deposition depends on severity:
- Mild: observation for 4-6 hours, discharge if mental status and vital signs remain normal
- Moderate: admit for observation and symptom resolution
- Severe: ICU care
Resumption of causative agents
The decision to resume serotonergic agent depends on the risk of recurrence and the benefits of use of the agent.
It should be noted that in some cases, serotonergic signs may be persistently present that meet the diagnostic criteria for serotonin syndrome but patient benefits more to continue use of the agent, given that the signs are tolerable.
In such cases, extreme care should be given to not add other serotonergic drugs to the regimen.